Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > upcoming ... 2 events ... June 25 and June 26

<< Previous

Bullboard Posts

Next >>

Comment by porksnifferon Jun 19, 2020 11:27am

77 Views

Post# 31169471

RE:RE:RE:RE:RE:upcoming ... 2 events ... June 25 and June 26

MUGMODs wrote: To answer your question directly, they probably don't want to deal with whining, crying little babies. They want good questions in a virtual setting that help the most number of people get some understanding.

That's just off the top of my head ... but ... I don't know.

: )

Yes, they only take positive questions from bullish pom-pom carrying cucks. One thing is for sure, the CEO will speak no more than 5-6 sentences at the entire meeting.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle